Generating Metabolically Active Hepatocytes from Pluripotent Stem Cells

Add bookmark

Generating Metabolically Active Hepatocytes from Pluripotent Stem Cells

Add bookmark

Dr. David Hay, Principal Investigator at the MRC Centre for Regenerative Medicine, joins Helen Winsor from Pharma IQ, to discuss the challenges and potential of metabolically active hepatocytes, covering the following areas:

  • Insights into polymer screening to identify culture matrices which can regulate cell phenotypes
  • How to achieve stability using a novel polymer matrix
  • How high through-put polymer screening can be applied to enhance the stability of stem cell models
  • The future development of stem cell use in predictive toxicology

[inlinead]


Upcoming Events

Pharma Contract Manufacturing

23 - 25 March 2026

Mercure Hotel MOA Berlin, Germany

Pharma Contract Manufacturing

SmartLab Exchange USA

April 20-21, 2026

The Logan, Philadelphia, USA

SmartLab Exchange USA

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended